IN order to ensure opportunities for the publication of the scientific results of cancer research, a group of representatives of interested organizations are to co-operate in making possible a new journal Cancer Research, to be devoted to articles and abstracts of articles having to do with cancer research. This journal is sponsored by the American Association for Cancer Research, the Anna Fuller Fund, the International Cancer Research Foundation, and the Jane Coffin Childs Memorial Fund for Medical Research. It is hoped to start publication with the issue of January, 1941. Manuscripts should be addressed to the Secretary of the Editorial Committee, 333 Cedar Street, New Haven, Connecticut. Subscriptions are now being received at the office of the Business Manager, American Oncologic Hospital, 33rd Street and Powelton Avenue, Philadelphia. Annual subscription, one volume of twelve issues per year, will be: to members of the American Association for Cancer Research, five dollars; to non-members, seven dollars.

The main components of the cancer research continuum are basic/preclinical research, early and late clinical research and, after the adoption of an innovation by the healthcare or health organisations, outcomes research. Translational cancer research, defined as a coherent cancer research continuum, is mandatory to address the increasing burden of cancer effectively. The growing cancer problem can only be significantly modified by concerted action involving prevention to decrease incidence, early detection and treatment to increase the cure rate, and personalised/precision cancer medicine to adapt early detection and treatment to the biology of a tumour with the aim of increasing the cure rate, prolonging survival and improving health‐related quality of life. By definition, translational cancer research for therapeutics has a focus on patients’ needs and for prevention for individuals at‐risk. Consequently, to increase the effectiveness of translational research, the different components of the cancer research continuum need to be better connected to the fundamental aim of a mission‐oriented approach to cancer (Celis and Pavalkis, 2017).

Medical Journal of AustraliaVolume 1, Issue 8 p. 275-276 Cancer Research CANCER RESEARCH First published: 01 February 1927 https://doi.org/10.5694/j.1326-5377.1927.tb12441.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume1, Issue8February 1927Pages 275-276 RelatedInformation

A SUMMARY of recent progress in cancer research is to be found in the fourteenth annual report of the British Empire Cancer Campaign and the thirty-fifth annual report of the Imperial Cancer Research Fund, which were published at the end of 1937. Work from widely distributed centres is described, and the two reports indicate the lines along which the problem of cancer is being attacked.

Current cancer research 2006 , Current cancer research 2006 , کتابخانه دیجیتال جندی شاپور اهواز

With over one third of the UK population at risk of developing some form of cancer during their lifetime, the need for a better understanding of how cancer is caused and develops is evident. This necessity has presumably underlined the recent launch of the National Cancer Research Institute and Network schemes by the UK government. The Institute – the first of its kind in the UK to focus on a specific disease – will oversee and coordinate the research activities of all existing cancer research councils and institutes, health departments and pharmaceutical companies. Furthermore, the National Cancer Research Network aims to expand the number of patients in clinical trials to improve the availability of disease statistics and to recruit additional specialist staff. It is hoped that these initiatives and the concomitant funding will promote more intensive research into cancer and the advancement of effective medicines for this disease. DC

THE annual general meeting of the Imperial Cancer Research Fund was held at the Examination Hall, Queen Square, Bloomsbury, on July 23, his Grace the Duke of Bedford, K.G., in the chair.

Cancer research has been severely impacted by COVID-19. What does the future of cancer research look like in the new year after the pandemic?

IN March 1933 the International Cancer Research Foundation, established by Mr. William H. Donner of Philadelphia, awarded a sum of £1,000 per annum for a period of two years to the Research Institute of the Cancer Hospital (Free), London, in support of investigations into factors which underlie the origin of malignant growths. This grant has provided two research scholarships which are held by G. A. D. Haslewood, who is working with Dr. J. W. Cook in the Research Institute, and by Miss Edna Roe, who is studying the molecular structure of carcinogenic compounds by physical methods, under Dr. Mayneord in the Physics Section of the Radiological Department of the Cancer Hospital. The grant has also defrayed a part of the cost of this work. Under the direction of Dr. Cook, Haslewood has recently prepared a very active cancer-producing compound, methylcholanthrene, from another compound, deoxycholic acid, which is known to occur in the human body. To assist in further developments of this work, the Trustees of the International Cancer Research Foundation have now decided that this grant shall be continued for an additional three years, untir June 1, 1938.

SEVERAL of the papers in the Ninth Scientific Report on the Investigations of the Imperial Cancer Research Fund (London: Taylor and Francis, 1930. 20s.) deal with the fowl tumours which can be transmitted from bird to bird by tumour extracts filtered through filters so fine that the infective filtrate contains nothing large enough to be clearly visible under the highest powers of the microscope. The nature of this ‘agent’ is the most crucial question of current theoretical cancer research. It may, on one hand, be analogous to the invisible viruses which are associated with so many infectious diseases in animals and plants; it may, on the other hand, be a special example of the chemical substances arising from the disintegration or injury of cells which promote tissue growth. The ‘agent’ by which transmission is effected may, in short, arise in the cancer cell or may come into the body from outside.